Yin Ling Woo

5.4k total citations
58 papers, 1.3k citations indexed

About

Yin Ling Woo is a scholar working on Epidemiology, Oncology and Surgery. According to data from OpenAlex, Yin Ling Woo has authored 58 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Epidemiology, 22 papers in Oncology and 10 papers in Surgery. Recurrent topics in Yin Ling Woo's work include Cervical Cancer and HPV Research (27 papers), Global Cancer Incidence and Screening (13 papers) and BRCA gene mutations in cancer (9 papers). Yin Ling Woo is often cited by papers focused on Cervical Cancer and HPV Research (27 papers), Global Cancer Incidence and Screening (13 papers) and BRCA gene mutations in cancer (9 papers). Yin Ling Woo collaborates with scholars based in Malaysia, United Kingdom and United States. Yin Ling Woo's co-authors include Margaret Stanley, Reena Rajasuriar, Jane Sterling, Maria Kyrgiou, Heather O Dickinson, Andrew Bryant, Thomas R. Everett, Noor Azmi Mat Adenan, Ivy Chung and Zahurin Mohamed and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

In The Last Decade

Yin Ling Woo

57 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yin Ling Woo Malaysia 22 465 388 304 221 208 58 1.3k
Θεόδωρος Αγοραστός Greece 24 682 1.5× 269 0.7× 288 0.9× 316 1.4× 430 2.1× 100 1.5k
Jens Einenkel Germany 22 407 0.9× 390 1.0× 184 0.6× 273 1.2× 409 2.0× 51 1.3k
Thomas Ehlen Canada 19 663 1.4× 248 0.6× 306 1.0× 329 1.5× 171 0.8× 35 1.5k
C. David Wrede Australia 20 988 2.1× 761 2.0× 336 1.1× 294 1.3× 260 1.3× 52 1.6k
Jeffrey Low Singapore 21 292 0.6× 442 1.1× 696 2.3× 332 1.5× 233 1.1× 51 2.0k
Dana M. Chase United States 26 736 1.6× 564 1.5× 674 2.2× 320 1.4× 366 1.8× 115 2.3k
HC Kitchener United Kingdom 19 852 1.8× 329 0.8× 133 0.4× 323 1.5× 401 1.9× 48 1.5k
Devansu Tewari United States 12 381 0.8× 202 0.5× 182 0.6× 219 1.0× 124 0.6× 32 795
Damrong Tresukosol Thailand 17 531 1.1× 340 0.9× 348 1.1× 577 2.6× 385 1.9× 48 1.5k
Siobhán O’Connor United States 19 250 0.5× 221 0.6× 284 0.9× 113 0.5× 89 0.4× 51 1.1k

Countries citing papers authored by Yin Ling Woo

Since Specialization
Citations

This map shows the geographic impact of Yin Ling Woo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yin Ling Woo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yin Ling Woo more than expected).

Fields of papers citing papers by Yin Ling Woo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yin Ling Woo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yin Ling Woo. The network helps show where Yin Ling Woo may publish in the future.

Co-authorship network of co-authors of Yin Ling Woo

This figure shows the co-authorship network connecting the top 25 collaborators of Yin Ling Woo. A scholar is included among the top collaborators of Yin Ling Woo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yin Ling Woo. Yin Ling Woo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Steben, Marc, Suzanne M. Garland, Yin Ling Woo, et al.. (2025). An updated understanding of the natural history of cervical human papillomavirus infection—clinical implications. American Journal of Obstetrics and Gynecology. 232(5). 453–460. 5 indexed citations
2.
Garland, Suzanne M., et al.. (2024). IPVS STATEMENT on HPV vaccination: No longer supply constraints: Towards achieving WHO vaccine targets. Vaccine. 42(26). 126400–126400. 2 indexed citations
3.
Tse, Ka Yu, Ai Ling Tan, K. D. Subedi, et al.. (2024). The AOFOG recommendations on human papillomavirus vaccination in the Asia‐Pacific region. Journal of obstetrics and gynaecology research. 50(S1). 95–102. 1 indexed citations
4.
Woo, Yin Ling, et al.. (2024). Pipelle Endometrial Sampling With a Full Bladder Compared With Standard Care. Obstetrics and Gynecology. 144(1). 53–59.
5.
Bateson, Deborah, et al.. (2024). Enhancing equity in cervical screening – initiatives to increase screening participation. Current Opinion in Obstetrics & Gynecology. 36(5). 345–352. 2 indexed citations
6.
Luckett, Rebecca, Sarah Feldman, Yin Ling Woo, et al.. (2023). COVID-19 as a catalyst for reimagining cervical cancer prevention. eLife. 12. 5 indexed citations
7.
Rajasuriar, Reena, et al.. (2022). Changes in genital Human Papillomavirus (HPV) prevalence among urban females a decade after the Malaysian HPV vaccination program. PLoS ONE. 17(12). e0278477–e0278477. 6 indexed citations
8.
Lee, Yew Kong, et al.. (2021). Decision-making for Risk-reducing Salpingo-oophorectomy (RRSO) in Southeast Asian BRCA Mutation Carriers With Breast Cancer: A Qualitative Study. International Journal of Behavioral Medicine. 29(1). 1–13. 6 indexed citations
9.
Gravitt, Patti E., Michelle I. Silver, Heather M. Hussey, et al.. (2021). Achieving equity in cervical cancer screening in low- and middle-income countries (LMICs): Strengthening health systems using a systems thinking approach. Preventive Medicine. 144. 106322–106322. 35 indexed citations
10.
Rajasuriar, Reena, et al.. (2020). The Acceptability and Preference of Vaginal Self-sampling for Human Papillomavirus (HPV) Testing among a Multi-ethnic Asian Female Population. Cancer Prevention Research. 14(1). 105–112. 21 indexed citations
11.
Brotherton, Julia, Julia Brotherton, Cristyn Davies, et al.. (2019). IPVS policy statement. Equity in cervical cancer prevention: for all and not just for some. Papillomavirus Research. 9. 100192–100192. 7 indexed citations
12.
Lee, Soo Ching, Tsung Fei Khang, Iskandar Azwa, et al.. (2018). Enrichment of gut-derived Fusobacterium is associated with suboptimal immune recovery in HIV-infected individuals. Scientific Reports. 8(1). 14277–14277. 64 indexed citations
13.
Subramaniam, Shridevi, Yek‐Ching Kong, Karuthan Chinna, et al.. (2018). Health‐related quality of life and psychological distress among cancer survivors in a middle‐income country. Psycho-Oncology. 27(9). 2172–2179. 37 indexed citations
14.
15.
Hasmad, Hanis Nazihah, Wei Wen, Daniel J. Park, et al.. (2015). Evaluation of germline BRCA1 and BRCA2 mutations in a multi-ethnic Asian cohort of ovarian cancer patients. Gynecologic Oncology. 141(2). 318–322. 16 indexed citations
16.
Woo, Yin Ling, et al.. (2012). Does the Success of a School-based HPV Vaccine Programme Depend on Teachers' Knowledge and Religion? - a Survey in a Multicultural Society. Asian Pacific Journal of Cancer Prevention. 13(9). 4651–4654. 17 indexed citations
17.
Woo, Yin Ling & Siti Zawiah Omar. (2011). Human papillomavirus vaccination in the resourced and resource-constrained world. Best Practice & Research Clinical Obstetrics & Gynaecology. 25(5). 597–603. 4 indexed citations
18.
Winder, David M., Yin Ling Woo, Jane Sterling, et al.. (2009). Sensitive HPV detection in oropharyngeal cancers. BMC Cancer. 9(1). 440–440. 31 indexed citations
19.
Woo, Yin Ling, et al.. (2008). Characterising the local immune responses in cervical intraepithelial neoplasia: a cross‐sectional and longitudinal analysis. BJOG An International Journal of Obstetrics & Gynaecology. 115(13). 1616–1622. 50 indexed citations
20.
Woo, Yin Ling, et al.. (2002). Danaparoid thromboprophylaxis in pregnant women with heparin‐induced thrombocytopenia. BJOG An International Journal of Obstetrics & Gynaecology. 109(4). 466–468. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Θεόδωρος Αγοραστός Breakdown of academic impact, for papers by Jens Einenkel Breakdown of academic impact, for papers by Thomas Ehlen Breakdown of academic impact, for papers by C. David Wrede Breakdown of academic impact, for papers by Jeffrey Low Breakdown of academic impact, for papers by Dana M. Chase Breakdown of academic impact, for papers by HC Kitchener Breakdown of academic impact, for papers by Devansu Tewari Breakdown of academic impact, for papers by Damrong Tresukosol Breakdown of academic impact, for papers by Siobhán O’Connor
Rankless by CCL
2026